[Biocompatibility of self-designed absorbable hydroxyapatite/poly (DL-lactide) composites]

Area of Science:

• Biomaterials Science
• Medical Device Materials
• Tissue Engineering

Background:

• Hydroxyapatite and poly (DL-lactide) are widely used biomaterials.
• Developing composite materials with enhanced properties is crucial for medical applications.
• Assessing the biocompatibility of novel composite materials is a critical step before clinical use.

Purpose of the Study:

• To evaluate the in vitro and in vivo biocompatibility of self-designed hydroxyapatite/poly (DL-lactide) composite rods.
• To determine the safety profile of the composite material for potential biomedical applications.

Main Methods:

• In vitro tests included Ames test, micronucleus test, hemolysis test, and hemopexis test.
• In vivo tests comprised acute and subacute systemic toxicity studies and long-term muscle and bone implantation.
• Standardized protocols were followed for all toxicological and implantation assessments.

Main Results:

• The hydroxyapatite/poly (DL-lactide) composite showed no evidence of mutagenicity or genotoxicity (Ames, micronucleus tests).
• Hemolysis and hemopexis tests indicated no adverse effects on blood components.
• Systemic toxicity and long-term implantation studies revealed no significant adverse reactions, inflammation, or toxicity.

Conclusions:

• The self-designed hydroxyapatite/poly (DL-lactide) composite material exhibits excellent biocompatibility.
• The material is safe for use in biomedical applications, showing no toxicity, mutagenicity, or adverse hemocompatic effects.
• These findings support the potential of this composite for use in bone regeneration and other medical implants.